Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ASXC Asensus Surgical	$0.35	$0.35	$0.17 ▼ $0.40	$94.74M	1.37	2.03 million shs	N/A
CLPT ClearPoint Neuro	$11.92 +13.1%	$11.51	$9.40 ▼ $19.22	$333.64M	0.85	315,871 shs	869,349 shs
NNOX Nano-X Imaging	$4.55 +2.2%	$5.09	$3.75 ▼ $11.00	$262.90M	1.95	1.78 million shs	1.75 million shs
STIM Neuronetics	$3.87 +0.3%	$3.83	$0.52 ▼ $5.92	$255.90M	1.78	1.21 million shs	1.59 million shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ASXC Asensus Surgical	0.00%	0.00%	0.00%	0.00%	+4.32%
CLPT ClearPoint Neuro	-0.57%	+0.09%	-7.54%	-15.21%	+7.77%
NNOX Nano-X Imaging	-5.62%	-9.00%	-12.06%	-20.68%	-33.88%
STIM Neuronetics	-1.53%	-15.16%	+8.12%	-10.23%	+418.12%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ASXC Asensus Surgical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CLPT ClearPoint Neuro	2.2287 of 5 stars	3.5	3.0	0.0	0.0	1.7	0.8	0.6
NNOX Nano-X Imaging	2.5428 of 5 stars	3.8	3.0	0.0	0.0	2.8	0.0	0.6
STIM Neuronetics	1.9895 of 5 stars	3.5	1.0	0.0	0.0	2.9	0.8	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ASXC Asensus Surgical	0.00	N/A	N/A	N/A
CLPT ClearPoint Neuro	3.00	Buy	$19.67	64.99% Upside
NNOX Nano-X Imaging	3.50	Strong Buy	$8.50	86.81% Upside
STIM Neuronetics	3.00	Buy	$5.00	29.20% Upside

Current Analyst Ratings Breakdown

Latest ASXC, CLPT, NNOX, and STIM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$10.00 ➝ $8.00
8/11/2025	NNOX Nano-X Imaging	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/6/2025	STIM Neuronetics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$8.00 ➝ $7.00
8/1/2025	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$8.00 ➝ $9.00
7/14/2025	NNOX Nano-X Imaging	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/6/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00
5/23/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$15.00 ➝ $10.00
5/22/2025	NNOX Nano-X Imaging	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy

(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ASXC Asensus Surgical	$8.58M	11.04	N/A	N/A	$0.13 per share	2.68
CLPT ClearPoint Neuro	$31.39M	10.63	N/A	N/A	$0.92 per share	12.96
NNOX Nano-X Imaging	$11.28M	23.31	N/A	N/A	$3.27 per share	1.39
STIM Neuronetics	$111.11M	2.30	N/A	N/A	$0.48 per share	8.06

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ASXC Asensus Surgical	-$78.43M	-$0.31	N/A	N/A	N/A	-902.25%	-184.10%	-114.75%	N/A
CLPT ClearPoint Neuro	-$18.91M	-$0.76	N/A	N/A	N/A	-64.51%	-78.09%	-51.33%	N/A
NNOX Nano-X Imaging	-$53.52M	-$0.90	N/A	N/A	N/A	-472.19%	-30.92%	-27.73%	N/A
STIM Neuronetics	-$43.71M	-$1.13	N/A	N/A	N/A	-43.47%	-156.36%	-35.69%	N/A

Latest ASXC, CLPT, NNOX, and STIM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	CLPT ClearPoint Neuro	-$0.20	-$0.21	-$0.01	-$0.21	$9.20 million	$9.22 million
8/12/2025	Q2 2025	NNOX Nano-X Imaging	-$0.15	-$0.23	-$0.08	-$0.23	$3.20 million	$3.04 million
8/5/2025	Q2 2025	STIM Neuronetics	-$0.08	-$0.15	-$0.07	-$0.15	$36.80 million	$38.11 million
5/22/2025	Q1 2025	NNOX Nano-X Imaging	-$0.23	-$0.21	+$0.02	-$0.21	$3.98 million	$3.00 million
5/13/2025	Q1 2025	CLPT ClearPoint Neuro	-$0.15	-$0.22	-$0.07	-$0.22	$8.21 million	$8.49 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ASXC Asensus Surgical	N/A	N/A	N/A	N/A	N/A
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
NNOX Nano-X Imaging	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ASXC Asensus Surgical	N/A	1.00	0.69
CLPT ClearPoint Neuro	N/A	3.53	2.57
NNOX Nano-X Imaging	N/A	5.30	5.16
STIM Neuronetics	1.76	2.02	1.84

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ASXC Asensus Surgical	9.35%
CLPT ClearPoint Neuro	30.08%
NNOX Nano-X Imaging	21.49%
STIM Neuronetics	53.59%

Insider Ownership

Company	Insider Ownership
ASXC Asensus Surgical	2.87%
CLPT ClearPoint Neuro	6.11%
NNOX Nano-X Imaging	N/A
STIM Neuronetics	9.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ASXC Asensus Surgical	170	272.33 million	264.52 million	Not Optionable
CLPT ClearPoint Neuro	110	27.99 million	26.28 million	Optionable
NNOX Nano-X Imaging	190	57.78 million	N/A	Optionable
STIM Neuronetics	180	66.13 million	59.65 million	Optionable

ASXC, CLPT, NNOX, and STIM Headlines

Recent News About These Companies

Citizens Financial Group Inc. RI Invests $305,000 in Neuronetics, Inc. (NASDAQ:STIM)

August 10 at 4:38 AM | marketbeat.com

Canaccord Genuity Group Has Lowered Expectations for Neuronetics (NASDAQ:STIM) Stock Price

August 7, 2025 | marketbeat.com

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 6, 2025 | globenewswire.com

Neuronetics, Inc. (NASDAQ:STIM) Q2 2025 Earnings Call Transcript

August 6, 2025 | msn.com

Neuronetics (NASDAQ:STIM) Announces Quarterly Earnings Results, Misses Expectations By $0.07 EPS

August 6, 2025 | marketbeat.com

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

August 5, 2025 | seekingalpha.com

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

August 5, 2025 | manilatimes.netM

What To Expect From Neuronetics Inc (STIM) Q2 2025 Earnings

August 5, 2025 | finance.yahoo.com

Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates

August 5, 2025 | zacks.com

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

August 4, 2025 | globenewswire.com

Neuronetics Study Shows Strong Antidepressant Results for Teens and Young Adults Using NeuroStar TMS

August 2, 2025 | msn.com

Neuronetics (STIM) Projected to Post Earnings on Tuesday

July 30, 2025 | marketbeat.com

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

July 30, 2025 | globenewswire.com

Kestra Private Wealth Services LLC Purchases Shares of 68,977 Neuronetics, Inc. (NASDAQ:STIM)

July 29, 2025 | marketbeat.com

Nkcfo LLC Takes Position in Neuronetics, Inc. (NASDAQ:STIM)

July 28, 2025 | marketbeat.com

CenterBook Partners LP Invests $1.20 Million in Neuronetics, Inc. (NASDAQ:STIM)

July 17, 2025 | marketbeat.com

Neuronetics taps local industry veteran as new CFO

July 15, 2025 | bizjournals.com

Neuronetics Names Pfanstiel as CFO to Succeed Furlong

July 15, 2025 | marketwatch.com

Neuronetics Appoints New Chief Financial Officer

July 15, 2025 | finance.yahoo.com

Neuronetics names Steven Pfanstiel chief financial officer

July 15, 2025 | massdevice.com

Neuronetics Appoints New Chief Financial Officer

July 15, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASXC, CLPT, NNOX, and STIM Company Descriptions

Asensus Surgical NYSEAMERICAN:ASXC

$0.35 0.00 (0.00%)

As of 08/22/2024

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

ClearPoint Neuro NASDAQ:CLPT

$11.92 +1.38 (+13.09%)

Closing price 04:00 PM Eastern

Extended Trading

$11.91 -0.01 (-0.08%)

As of 07:56 PM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Nano-X Imaging NASDAQ:NNOX

$4.55 +0.10 (+2.25%)

Closing price 04:00 PM Eastern

Extended Trading

$4.58 +0.04 (+0.77%)

As of 07:57 PM Eastern

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Neuronetics NASDAQ:STIM

$3.87 +0.01 (+0.26%)

Closing price 04:00 PM Eastern

Extended Trading

$3.97 +0.10 (+2.58%)

As of 07:50 PM Eastern

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time